The broad picture of NHS performance over the last seven years or so does not look encouraging. Of the trends across ten measures of service quality, seven have deteriorated and are currently on trend for even poorer performance; two (MRSA and C. difficile) have plateaued, following improvement in previous years; and one (diagnostic waiting times), while now on a downward trend, remains above target and similar to levels in 2011.
But there does appear to be an emerging answer to the question QualityWatch posed at its outset concerning the possible trade-off between performance and funding growth. Performance across a majority of the quality metrics analysed began to deteriorate three or four years into the period of much slower funding growth for the NHS.
With current Government spending plans for the next five years to 2022/23 set to continue the relatively low growth of the last seven years, it remains to be seen whether trends in many of the key quality measures examined here will continue on the deteriorating paths they have taken over the last few years, or whether the NHS can find new ways to reverse these trends.
Following the 2017 Autumn Budget settlement for the NHS over the next few years, the view of the NHS England board is that “even with some increased volume, and even assuming this year's [2017/18] unprecedented elective demand management success continues, our current forecast is that – without offsetting reductions in other areas of care – NHS constitution waiting times standards, in the round, will not be fully funded and met next year.”
In other words, the opportunity cost of stabilising current overspending by trusts and prioritising emergency and primary care services may well be further deterioration in elective waiting lists and waiting times.
Think the NHS is safe in Tory hands?
Think again.
Reference.
The Kings Fund report 1997-2010
The Nuffield Trust, trends in the NHS 2010-2017.